PRESS RELEASE
News
-
-
-
PRESS RELEASE
Lindt & Sprüngli again achieves strong organic growth
Lindt & Sprüngli achieved strong organic growth in 2024, with sales increasing by 5.1% to CHF 5.47 billion. Despite cocoa cost challenges, the Group's results exceeded expectations, positioning them as a top chocolate manufacturer worldwide -
-
PRESS RELEASE
Personnel change on the Implenia Board of Directors
Implenia AG announces personnel change on the Board of Directors: Martin Fischer to step down in March 2025, Marie-Noëlle Zen-Ruffinen to be proposed as new member. Details on the accomplished career and background of Marie-Noëlle Zen-Ruffinen -
-
-
REGULATED PRESS RELEASE
Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101
Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101. L'objectif est de co-développer et commercialiser le traitement en Chine -
REGULATED PRESS RELEASE
Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101
Biophytis enters exclusive negotiations with a Chinese pharmaceutical company to license BIO101 for viral respiratory infections, sarcopenia, and obesity. The potential partnership aims to develop and commercialize the drug in China's growing pharmaceutical market -
